Literature DB >> 31897882

Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles.

Meiting Zhou1, Qinfu Zhao2, Yifan Wu2, Shuang Feng2, Da Wang2, Ying Zhang3, Siling Wang4.   

Abstract

Mesoporous carriers have been widely used to deliver anticancer drugs due to their unique characteristics. In this work, mesoporous silica nanoparticles (MSN) and mesoporous carbon nanoparticles (MCN) with substantially similar and uniform particle size, specific surface area, and pore size were prepared to compare the photothermal effect, drug loading efficiencies (LE), and drug release properties. In order to improve the dispersion stability and biocompatibility of the carriers, MSN and MCN were grafted with PEG, respectively. The NIR-induced photothermal effect results indicated that MCN had a brilliant photothermal conversion efficiency due to its strong near-infrared absorption capacity, while MSN had no photothermal conversion capability. Moreover, LE of DOX in DOX/MCN-PEG reached 36.58%, higher than that in DOX/MSN-PEG, which was ascribed to non-covalent interaction of π-π stacking and electrostatic attraction. In addition, compared to DOX/MSN-PEG, DOX/MCN-PEG had a significantly increased release rate under NIR laser irradiation due to excellent photothermal conversion capability of MCN-PEG. Furthermore, cell viability assay and cellular uptake experiment results demonstrated that DOX/MCN-PEG showed a synergistic therapeutic effect in the combination of chemotherapy and phototherapy, with a combination index (CI) of 0.238.

Entities:  

Keywords:  chemo-photothermal therapy; doxorubicin; loading efficiency; mesoporous carbon; mesoporous silica

Mesh:

Substances:

Year:  2020        PMID: 31897882     DOI: 10.1208/s12249-019-1604-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  2 in total

1.  Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy.

Authors:  Lun Zhang; Shuiqing Gui; Yinghua Xu; Jiali Zeng; Jian Wang; Qingru Chen; Liqian Su; Ziyan Wang; Rui Deng; Fujiang Chu; Wenbin Liu; Xiaobao Jin; Xuemei Lu
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

2.  IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation.

Authors:  Yongmei Wang; Haibo Wang; Yuhua Song; Meng Lv; Yan Mao; Hongming Song; Yuanyuan Wang; Gang Nie; Xiaoyi Liu; Jian Cui; Xueqing Zou
Journal:  J Nanobiotechnology       Date:  2022-03-02       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.